Core Viewpoint - Bon Natural Life Limited has regained compliance with Nasdaq's continued listing requirements, allowing it to maintain its listing on the Nasdaq Capital Market [1][2]. Group 1: Compliance and Listing Status - On July 2, 2025, Bon Natural Life Limited received confirmation from the Nasdaq Hearings Panel that it has met the Minimum Bid Price Requirement under Nasdaq Listing Rule 5550(a)(2) [2]. - The Panel granted the Company's request to maintain its listing after Bon Natural Life Limited submitted a compliance plan on May 16, 2025, and presented its case during a hearing on June 5, 2025 [2]. - The Company will remain under a Discretionary Panel Monitor for one year, during which Nasdaq will oversee its ongoing compliance with all continued listing standards [3]. Group 2: Company Overview - Bon Natural Life Limited is a Cayman Islands company engaged in the natural, health, and personal care industries [4].

Core Insights - Bon Natural Life Limited (BON) has entered a non-exclusive sales cooperation agreement with Shanghai Risesun International Trade Co., Ltd. for a total contract value of US$ 24 million over 24 months [1] - The agreement focuses on marketing, distributing, and selling BON's tea pigment series health products in China [1] - Tea pigments are gaining traction in the digestive wellness and blood glucose regulation sectors, with potential for a market valuation exceeding $1 billion [2] Company Developments - CEO Hu Yongwei emphasized that the collaboration with Shanghai Risesun will accelerate BON's entry into the high-growth digestive health sector [3] - The partnership is seen as a strategic milestone for BON, enhancing its position in the tea pigment-based product market [3] - The company anticipates that this alliance will drive revenue and earnings growth, benefiting shareholder returns through sustainable market expansion [3]